View in EDS HTML Full Text PDF Full Text

Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.

Saved in:
Bibliographic Details
Title: Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.
Authors: Gaston TE; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA., Bebin EM; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA., Cutter GR; Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA., Grayson L; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA., Szaflarski JP; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Source: Epilepsia open [Epilepsia Open] 2023 Dec; Vol. 8 (4), pp. 1405-1412. Date of Electronic Publication: 2023 Aug 26.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101692036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9239 (Electronic) Linking ISSN: 24709239 NLM ISO Abbreviation: Epilepsia Open Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37593907
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gaston+TE%22">Gaston TE</searchLink>; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Bebin+EM%22">Bebin EM</searchLink>; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Cutter+GR%22">Cutter GR</searchLink>; Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Grayson+L%22">Grayson L</searchLink>; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Szaflarski+JP%22">Szaflarski JP</searchLink>; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101692036%22">Epilepsia open</searchLink> [Epilepsia Open] 2023 Dec; Vol. 8 (4), pp. 1405-1412. <i>Date of Electronic Publication: </i>2023 Aug 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101692036 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2470-9239 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224709239%22">24709239 </searchLink><i>NLM ISO Abbreviation: </i>Epilepsia Open <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37593907
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/epi4.12815
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1405
    Titles:
      – TitleFull: Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gaston TE
      – PersonEntity:
          Name:
            NameFull: Bebin EM
      – PersonEntity:
          Name:
            NameFull: Cutter GR
      – PersonEntity:
          Name:
            NameFull: Grayson L
      – PersonEntity:
          Name:
            NameFull: Szaflarski JP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2023 Dec
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2470-9239
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Epilepsia open
              Type: main
ResultId 1